Kostas Biliouris's Stock Ratings

BMO Capital Analyst

Kostas Biliouris is an analyst at BMO Capital. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/18/2025

Overall Average Return

-17.3%

Smart Score

35.6%

Overall Average Return Percentile

14th

Number of Ratings

56
Buy NowGet Alert
03/12/2025RNABuy Now
Avidity Biosciences
$30.48136.22%
Kostas Biliouris35%
→ $72Initiates → OutperformGet Alert
03/12/2025RCKTBuy Now
Rocket Pharmaceuticals
$8.67476.7%
Kostas Biliouris35%
→ $50Initiates → OutperformGet Alert
03/12/2025DYNBuy Now
Dyne Therapeutics
$12.58297.46%
Kostas Biliouris35%
→ $50Initiates → OutperformGet Alert
03/04/2025SLNBuy Now
Silence Therapeutics
$3.99526.57%
Kostas Biliouris35%
$67 → $25MaintainsOutperformGet Alert
02/20/2025IONSBuy Now
Ionis Pharmaceuticals
$33.1535.75%
Kostas Biliouris35%
$60 → $45MaintainsMarket PerformGet Alert
01/10/2025NTLABuy Now
Intellia Therapeutics
$9.20443.48%
Kostas Biliouris35%
$70 → $50MaintainsOutperformGet Alert
01/10/2025DTILBuy Now
Precision BioSciences
$5.05573.27%
Kostas Biliouris35%
$34 → $34UpgradeMarket Perform → OutperformGet Alert
09/16/2024CNTABuy Now
Centessa Pharmaceuticals
$16.51111.99%
Kostas Biliouris35%
$20 → $35MaintainsOutperformGet Alert
09/09/2024CNTABuy Now
Centessa Pharmaceuticals
$16.5121.14%
Kostas Biliouris35%
$15 → $20MaintainsOutperformGet Alert
08/15/2024MGXBuy Now
Metagenomi
$1.88804.4%
Kostas Biliouris35%
$22 → $17MaintainsOutperformGet Alert
08/02/2024IONSBuy Now
Ionis Pharmaceuticals
$33.1581%
Kostas Biliouris35%
$67 → $60DowngradeOutperform → Market PerformGet Alert
07/18/2024FDMTBuy Now
4D Molecular Therapeutics
$3.82947.12%
Kostas Biliouris35%
$63 → $40MaintainsOutperformGet Alert
07/03/2024LEGNBuy Now
Legend Biotech
$37.88137.59%
Kostas Biliouris35%
$90 → $90MaintainsOutperformGet Alert
06/24/2024ALNYBuy Now
Alnylam Pharmaceuticals
$244.30-4.22%
Kostas Biliouris35%
$234 → $234MaintainsOutperformGet Alert
06/24/2024SRPTBuy Now
Sarepta Therapeutics
$73.36172.63%
Kostas Biliouris35%
$170 → $200MaintainsOutperformGet Alert
06/18/2024SRPTBuy Now
Sarepta Therapeutics
$73.36131.73%
Kostas Biliouris35%
$170 → $170MaintainsOutperformGet Alert
06/14/2024SRPTBuy Now
Sarepta Therapeutics
$73.36131.73%
Kostas Biliouris35%
$170 → $170MaintainsOutperformGet Alert
05/15/2024KRROBuy Now
Korro Bio
$24.17396.48%
Kostas Biliouris35%
$120 → $120MaintainsOutperformGet Alert
05/10/2024NTLABuy Now
Intellia Therapeutics
$9.20660.87%
Kostas Biliouris35%
$62 → $70MaintainsOutperformGet Alert
04/01/2024CNTABuy Now
Centessa Pharmaceuticals
$16.51-9.15%
Kostas Biliouris35%
$15 → $15MaintainsOutperformGet Alert
04/01/2024FDMTBuy Now
4D Molecular Therapeutics
$3.821549.21%
Kostas Biliouris35%
$70 → $63MaintainsOutperformGet Alert
03/27/2024BEAMBuy Now
Beam Therapeutics
$22.76150.49%
Kostas Biliouris35%
→ $57MaintainsOutperformGet Alert
03/27/2024ALNYBuy Now
Alnylam Pharmaceuticals
$244.30-4.22%
Kostas Biliouris35%
$234 → $234MaintainsOutperformGet Alert
03/26/2024KRROBuy Now
Korro Bio
$24.17396.48%
Kostas Biliouris35%
$120 → $120ReiteratesOutperform → OutperformGet Alert
03/05/2024MGXBuy Now
Metagenomi
$1.881070.4%
Kostas Biliouris35%
→ $22Initiates → OutperformGet Alert
02/27/2024KRROBuy Now
Korro Bio
$24.17396.48%
Kostas Biliouris35%
→ $120Initiates → OutperformGet Alert
02/05/2024FDMTBuy Now
4D Molecular Therapeutics
$3.821732.46%
Kostas Biliouris35%
$50 → $70MaintainsOutperformGet Alert
01/31/2024BBIOBuy Now
BridgeBio Pharma
$31.5017.46%
Kostas Biliouris35%
→ $37Initiates → Market PerformGet Alert
01/31/2024SLNBuy Now
Silence Therapeutics
$3.991579.2%
Kostas Biliouris35%
→ $67Initiates → OutperformGet Alert
01/31/2024SRPTBuy Now
Sarepta Therapeutics
$73.36131.73%
Kostas Biliouris35%
→ $170Initiates → OutperformGet Alert
11/10/2023NTLABuy Now
Intellia Therapeutics
$9.20573.91%
Kostas Biliouris35%
$64 → $62MaintainsOutperformGet Alert
11/03/2023BMRNBuy Now
Biomarin Pharmaceutical
$71.5539.76%
Kostas Biliouris35%
$102 → $100MaintainsOutperformGet Alert
10/10/2023ALNYBuy Now
Alnylam Pharmaceuticals
$244.30-4.22%
Kostas Biliouris35%
$250 → $234MaintainsOutperformGet Alert
10/09/2023PRMEBuy Now
Prime Medicine
$1.80955.56%
Kostas Biliouris35%
→ $19Initiates → OutperformGet Alert
07/25/2023CNTABuy Now
Centessa Pharmaceuticals
$16.51-9.15%
Kostas Biliouris35%
$11 → $15MaintainsOutperformGet Alert
07/05/2023BMRNBuy Now
Biomarin Pharmaceutical
$71.5542.56%
Kostas Biliouris35%
→ $102UpgradeMarket Perform → OutperformGet Alert
05/05/2023ALNYBuy Now
Alnylam Pharmaceuticals
$244.302.33%
Kostas Biliouris35%
$200 → $250UpgradeMarket Perform → OutperformGet Alert
05/05/2023NTLABuy Now
Intellia Therapeutics
$9.20595.65%
Kostas Biliouris35%
$57 → $64MaintainsOutperformGet Alert
04/25/2023LEGNBuy Now
Legend Biotech
$37.88137.59%
Kostas Biliouris35%
$79 → $90MaintainsOutperformGet Alert
03/14/2023DTILBuy Now
Precision BioSciences
$5.05-20.79%
Kostas Biliouris35%
$210 → $120DowngradeOutperform → Market PerformGet Alert
03/14/2023NTLABuy Now
Intellia Therapeutics
$9.20519.57%
Kostas Biliouris35%
$54 → $57UpgradeMarket Perform → OutperformGet Alert
03/07/2023BMRNBuy Now
Biomarin Pharmaceutical
$71.5542.56%
Kostas Biliouris35%
$107 → $102MaintainsMarket PerformGet Alert
01/30/2023BMRNBuy Now
Biomarin Pharmaceutical
$71.5549.55%
Kostas Biliouris35%
→ $107Initiates → Market PerformGet Alert
01/30/2023FDMTBuy Now
4D Molecular Therapeutics
$3.821208.9%
Kostas Biliouris35%
→ $50Initiates → OutperformGet Alert
01/06/2023GRPHBuy Now
Graphite Bio
——
Kostas Biliouris35%
$98 → $49DowngradeOutperform → Market PerformGet Alert
12/20/2022BEAMBuy Now
Beam Therapeutics
$22.76190.04%
Kostas Biliouris35%
$61 → $66UpgradeMarket Perform → OutperformGet Alert
08/11/2022CNTABuy Now
Centessa Pharmaceuticals
$16.51-33.37%
Kostas Biliouris35%
$19 → $11MaintainsOutperformGet Alert
07/18/2022VERVBuy Now
Verve Therapeutics
$5.85959.83%
Kostas Biliouris35%
$48 → $62MaintainsOutperformGet Alert
06/17/2022LEGNBuy Now
Legend Biotech
$37.88103.27%
Kostas Biliouris35%
→ $77Initiates → OutperformGet Alert
06/17/2022VERVBuy Now
Verve Therapeutics
$5.85720.51%
Kostas Biliouris35%
→ $48Initiates → OutperformGet Alert
06/17/2022CRSPBuy Now
CRISPR Therapeutics
$40.91139.55%
Kostas Biliouris35%
→ $98Initiates → OutperformGet Alert
06/17/2022CNTABuy Now
Centessa Pharmaceuticals
$16.5115.08%
Kostas Biliouris35%
→ $19Initiates → OutperformGet Alert
06/17/2022DTILBuy Now
Precision BioSciences
$5.0538.61%
Kostas Biliouris35%
→ $210Initiates → OutperformGet Alert
06/17/2022GRPHBuy Now
Graphite Bio
——
Kostas Biliouris35%
→ $84Initiates → OutperformGet Alert
06/17/2022BEAMBuy Now
Beam Therapeutics
$22.7680.17%
Kostas Biliouris35%
→ $41Initiates → Market PerformGet Alert
06/17/2022NTLABuy Now
Intellia Therapeutics
$9.20486.96%
Kostas Biliouris35%
→ $54Initiates → Market PerformGet Alert